Calcium entry blockers in cerebral resuscitation

Area of Science:

• Neuroscience
• Pharmacology
• Cerebrovascular Medicine

Background:

• Cerebral ischemia triggers postischemic events that exacerbate neurologic injury.
• Intracellular calcium accumulation is a key factor in neuronal damage following ischemia.
• Calcium entry blockers (CEB) are investigated for their potential to mitigate ischemic brain injury.

Purpose of the Study:

• To review the influence of various calcium entry blockers (CEB) on postischemic cerebral blood flow (CBF) and neurologic outcomes.
• To discuss the role of intracellular calcium (Ca) in neuronal injury after cerebral ischemia.
• To evaluate the existing evidence for CEB efficacy in preventing calcium overload and improving outcomes.

Main Methods:

• Literature review of studies investigating CEB in cerebral ischemia.
• Analysis of experimental data on diverse CEB, including nimodipine, lidoflazine, flunarizine, and nicardipine.
• Examination of the effects of CEB on postischemic cerebral blood flow (CBF) and intracellular calcium (Ca) levels.

Main Results:

• CEB exhibit diverse and inconsistent effects on cerebral blood flow and neurologic outcomes.
• There is a lack of robust evidence demonstrating that CEB consistently prevent calcium loading in the brain post-ischemia.
• Nimodipine emerges as a potentially promising CEB, though its precise mechanisms remain unclear.

Conclusions:

• The mechanisms by which CEB affect cerebral ischemia are not fully understood.
• Further research is essential to clarify the role and efficacy of CEB in managing ischemic brain injury.
• Nimodipine warrants continued investigation for its therapeutic potential in cerebral ischemia.